| Literature DB >> 17913268 |
Jae-Youn Moon, Jong Won Chung, Ju Han Kim, Young Keun Ahn, Myung Ho Jeong.
Abstract
Effective anti-platelet treatment has a key role in the prevention of stent thrombosis in the drug-eluting stent (DES) era. However, despite of the use of anti-platelet agents, stent thrombosis occurs in approximately 1% of patients, with an increased likelihood of occurrence in high-risk patients or complex lesion subset of patients [1-4]. According to the previous report, triple anti-platelet therapy (aspirin+clopidogrel+cilostazol) seemed to be more effective in preventing thrombotic complications after stenting than dual anti-platelet agent [5]. But, in this report, we present a patient with subacute stent thrombosis (ST) involving two different arteries simultaneously under the use of triple anti-platelet regimen.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17913268 DOI: 10.1016/j.ijcard.2007.07.046
Source DB: PubMed Journal: Int J Cardiol ISSN: 0167-5273 Impact factor: 4.164